NCT05555446View on ClinicalTrials.gov

Bovine Colostrum to Prevent Absorption of Gluten

EARLY_PHASE1SuspendedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 22, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Celiac DiseaseGluten SensitivityNon-celiac Gluten Sensitivity
Interventions
DIETARY_SUPPLEMENT

Bovine colostrum

Subject will receive bovine colostrum with gluten.

DIETARY_SUPPLEMENT

Placebo

Subject will receive a placebo with gluten.

Trial Locations (1)

02115

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Milky Way Life Sciences LLC

INDUSTRY

NCT05555446 - Bovine Colostrum to Prevent Absorption of Gluten | Biotech Hunter | Biotech Hunter